VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2019 Feb; 26(2):619-627.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Albumins
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Pancreatic Ductal
Deoxycytidine
Female
Follow-Up Studies
Humans
Male
Middle Aged
Paclitaxel
Pancreatic Neoplasms
Prognosis
Retrospective Studies
Survival Rate
authors with profiles
ROBERT A WOLFF
ERIC P TAMM
GAURI R VARADHACHARY
MATTHEW HAROLD KATZ
MILIND JAVLE
DAVID FOGELMAN
RACHNA SHROFF
BRIAN WESTON
EUGENE JON KOAY
ANIRBAN MAITRA
CHING-WEI DAVID TZENG